← Back to Clinical Trials
Recruiting NCT06552286

NCT06552286 STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06552286
Status Recruiting
Phase
Sponsor Children's Hospital Medical Center, Cincinnati
Condition Autism Spectrum Disorder
Study Type INTERVENTIONAL
Enrollment 192 participants
Start Date 2024-07-10
Primary Completion 2029-12-31

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 21 Years
Study Type INTERVENTIONAL
Interventions
STRW-TPEERS-T

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 192 participants in total. It began in 2024-07-10 with a primary completion date of 2029-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The current study seeks to compare outcomes of a telehealth intervention targeting daily living skills (Surviving and Thriving in the Real World - Telehealth, or STRW-T) intervention to a control group telehealth intervention targeting social skills (Program for the Education and Enrichment of Relational Skills- Telehealth, or PEERS-T). The key endpoint will be change in daily living skills on primary and secondary outcome measures at the end of treatment.

Eligibility Criteria

Inclusion Criteria: * in the last 2 years of high school, or deferring graduation * diagnosis of ASD based on clinical judgement and/or meeting the cut-off score on the Autism Diagnostic Observation Schedule, 2nd Edition * full scale IQ of 70 or above as measured by the Wechsler Abbreviated Scale of Intelligence, 2nd Edition * deficient Daily Living Skills as assessed by the Vineland Adaptive Behavior Scales, 3rd Edition - at least 1 of the 3 Daily Living Skills subdomains is at least 15 points below their full scale IQ Exclusion Criteria: * significant aggressive behaviors or mental health issues that require treatment out of the scope of the current intervention. * if the adolescent has already completed the social skills group (PEERS), either at Cincinnati Children's or in another setting, unless it has been a significant amount of time since they did the PEERS group (2-3 years, or up to the discretion of the PI).

Contact & Investigator

Central Contact

Carrie Fassler

✉ carrie.fassler@cchmc.org

📞 5138033580

Principal Investigator

Amie Duncan, PhD

PRINCIPAL INVESTIGATOR

Children's Hospital Medical Center, Cincinnati

Frequently Asked Questions

Who can join the NCT06552286 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 21 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06552286 currently recruiting?

Yes, NCT06552286 is actively recruiting participants. Contact the research team at carrie.fassler@cchmc.org for enrollment information.

Where is the NCT06552286 trial being conducted?

This trial is being conducted at Carrboro, United States, Cincinnati, United States.

Who is sponsoring the NCT06552286 clinical trial?

NCT06552286 is sponsored by Children's Hospital Medical Center, Cincinnati. The principal investigator is Amie Duncan, PhD at Children's Hospital Medical Center, Cincinnati. The trial plans to enroll 192 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology